As of November 6, 2026, ClearPoint Neuro, Inc. is a publicly traded company (Nasdaq: CLPT); its largest reported holder is Bigger Michael, with 8.12% on Schedule 13G/A of November 3, 2026, then Mak Capital One LLC (7.8%). The largest insider holding is Joseph M. Burnett, the chief executive and president, with 322,108 shares (1.0% of shares outstanding), per Form 4 of September 3, 2026 (Schedule 13G/A, November 3, 2026).
Is this your company?
About to sign with, pay or invest in ClearPoint Neuro, Inc.? See the free Snapshot first.
Free to see. No signup.
Is ClearPoint Neuro, Inc. a real, registered company?
- ClearPoint Neuro, Inc. files with the SEC under CIK 1285550 (its SEC filings).
- Its shares are listed under the ticker CLPT on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Solana Beach, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under ClearPoint Neuro, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Bigger Michael (filed 2026-11-03).
Who are ClearPoint Neuro, Inc.'s owners and officers?
ClearPoint Neuro, Inc.: incorporated in Delaware; business address in Solana Beach, California; industry Surgical & Medical Instruments & Apparatus (Schedule 13G/A, 2026-11-03).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2026-02-05)
- : Director (Form D, 2026-02-05)
- : Director (Form D, 2026-02-05)
- : Director (Form D, 2026-02-05)
- : Director (Form D, 2026-02-05)
- : Director (Form D, 2026-02-05)
- : Director (Form D, 2026-02-05)
- : Director (Form D, 2026-02-05)
- : Executive Officer (Form D, 2026-02-05)
- : Executive Officer (Form D, 2026-02-05)
- : Executive Officer (Form D, 2026-02-05)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-11-03 | Bigger Michael | 8.12% |
| Schedule 13G/A, 2026-08-12 | Mak Capital One LLC | 7.8% |
| Schedule 13G/A, 2026-08-04 | Bigger Michael | 7.45% |
| Schedule 13G/A, 2026-07-27 | Blackrock, Inc. | 7.1% |
| Schedule 13G/A, 2026-05-15 | Mak Capital Fund LP | 6.3% |
| Schedule 13G/A, 2026-04-20 | Bigger Michael | 7.54% |
| Schedule 13G/A, 2026-03-26 | The Vanguard Group | 0% |
| Schedule 13G, 2026-03-13 | Mak Capital Fund LP | 6.1% |
| Schedule 13G/A, 2026-02-04 | Bigger Michael | 7.8% |
| Schedule 13G/A, 2025-11-12 | Bigger Michael | 7.6% |
| Schedule 13G/A, 2025-08-04 | Bigger Michael | 7.7% |
| Schedule 13G, 2025-07-29 | The Vanguard Group | 5.27% |
Questions about who owns ClearPoint Neuro, Inc.
Who owns ClearPoint Neuro, Inc.?
On this page, 4 holders' latest ownership filings report 5% or more of ClearPoint Neuro, Inc.: Bigger Michael (8.12%, Schedule 13G/A, filed 2026-11-03), Mak Capital One LLC (7.8%, Schedule 13G/A, filed 2026-08-12), Blackrock, Inc. (7.1%, Schedule 13G/A, filed 2026-07-27) and Mak Capital Fund LP (6.3%, Schedule 13G/A, filed 2026-05-15).
Who are the largest shareholders of ClearPoint Neuro, Inc.?
By the share each holder's latest filing reports, the largest holders of ClearPoint Neuro, Inc. on this page are Bigger Michael (8.12%), Mak Capital One LLC (7.8%) and Blackrock, Inc. (7.1%).
When did Bigger Michael buy into ClearPoint Neuro, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Bigger Michael on this page is the Schedule 13G/A, filed 2025-08-04, reporting 7.7%; its latest, Schedule 13G/A filed 2026-11-03, reports 8.12%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on ClearPoint Neuro, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on ClearPoint Neuro, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on ClearPoint Neuro, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
20 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own ClearPoint Neuro, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive and president: 322,108 shares (1.0% of shares outstanding), 130,720 held directly and 191,388 indirectly (Form 4, 2026-09-03).
- , a director: 132,004 shares (0.41% of shares outstanding) (Form 4, 2026-10-02).
- , a director: 110,623 shares (0.35% of shares outstanding) (Form 4, 2026-05-21).
- , the chief business officer: 110,263 shares (0.34% of shares outstanding) (Form 4, 2026-07-02).
- , the chief financial officer: 103,769 shares (0.32% of shares outstanding) (Form 4, 2026-07-02).
Shares outstanding: 32,054,268 as of 2026-10-21, from the company's latest SEC cover page.
How much has ClearPoint Neuro, Inc. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2026-02-05 | $17.89M | $17.89M |
Acquisitions reported on Form 8-K, Item 2.01: completed an acquisition (2025-11-20).
Keep reading
More on ClearPoint Neuro, Inc. and the records around it.
ClearPoint Neuro, Inc. elsewhere on the record
- 5%+ stake filings Nov 2026
- Form D filing Feb 2026
Companies that share a holder
- MAK CAPITAL ONE LLC also filed stake reports on 3 other companies: PERMA FIX ENVIRONMENTAL SERVICES INC (Aug 2026), STANDARD BIOTOOLS INC. (Aug 2026), HEIDRICK & STRUGGLES INTERNATIONAL INC (Nov 2025)
- MAK Capital Fund LP also filed stake reports on 7 other companies: Comstock Inc. (Oct 2026), Autolus Therapeutics plc (May 2026), STANDARD BIOTOOLS INC. (May 2026)
- BIGGER CAPITAL FUND L P also filed stake reports on 13 other companies: Dermata Therapeutics, Inc. (Nov 2026), BTC Digital Ltd. (Oct 2026), Neuraxis, INC (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/clearpoint-neuro